Effect of interleukin 2 on killer cell inhibitory receptors in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 60, Issue 2, 2001, Pages 166-169

  Kogure, T ^a   Niizawa, A ^a   Hai, L X ^a   Fujinaga, H ^a   Shimada, Y ^a   Ochiai, H ^a   Terasawa, K ^a  

^a TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE FUNCTION TEST; KILLER CELL; MALE; MOLECULAR CLONING; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTORS, IGG; RECEPTORS, IMMUNOLOGIC;

EID: 0035135626     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.2.166     Document Type: Article

References (29)

1. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
2. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
3. Molecular cloning of NKB1 a natural killer cell receptor for HLA-B allotypes
4. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
5. Immunoreceptor tyrosine-based inhibition motifs
6. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors
7. Major histcompatibility complex class I-specific receptors on human natural killer and T lymphocytes
8. Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-γ or interleukin-4
9. Natural killer function in systemic lupus erythematosus
10. Immune status in Crohn's disease V. Decreased in vitro natural killer activity in peripheral blood
11. Modulation of natural killer cell activity in the rheumatoid joint and peripheral blood
12. Cause of death in 81 autopsied patients with rheumatoid arthritis
13. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population
14. Rheumatoid arthritis complicated by mycobacterium tuberculosis. Are there characteristics predisposing to this association?
15. T cell responses to mycobacterium tuberculosis
16. Human alveolar T lymphocyte responses to mycobacterium tuberculosis antigens. Role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis
17. Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy
18. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
19. Therapeutic criteria in rheumatoid arthritis
20. Methods for enumerating lymphocyte population
21. The repertoire of HLA-Cw-specific NK cell receptors CD158a/b (EB6 and GL183) in individuals with different HLA phenotypes
22. NK cell receptors
23. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
24. Comparative studies of human FcR III-positive and negative natural killer cells
25. Biology of natural killer cells
26. Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus
27. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis
28. Natural killer cell activity in inflammatory joint disease
29. Natural killer cell-mediated cytotoxicity in Sjogrens syndrome and rheumatoid arthritis